The dual roles of homeobox genes in vascularization and wound healing

Cell Adhesion and Migration

Volumn 6, Issue 6, 2012, Pages 457-470

  Kachgal, Suraj ^a   Mace, Kimberly A ^b   Boudreau, Nancy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Endothelial cells; Hox genes; Inflammation; Tumor vascularization

Indexed keywords

HOMEODOMAIN PROTEIN;

ANGIOGENESIS; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; DISEASE COURSE; EMBRYO PATTERN FORMATION; GENE CONTROL; GENE FUNCTION; HOMEOSTASIS; PROTEIN FUNCTION; REVIEW; TISSUE ENGINEERING; VASCULARIZATION; WOUND HEALING;

EID: 84872063817     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22164     Document Type: Review

References (146)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-57; PMID:11001068; http://dx.doi.org/10.1038/35025220
2. Radisic M, Deen W, Langer R, Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 2005; 288: H1278-89; PMID:15539422; http://dx.doi.org/10.1152/ajpheart. 00787.2004
3. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000; 50:1-15; PMID: 11245270; http://dx.doi.org/10.1023/A:1006493130855
4. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2:549-58; PMID:9844628; http://dx.doi.org/10.1016/S1097-2765(00)80154-9
5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85:221-8; PMID:10436164; http://dx.doi.org/10.1161/01.RES.85.3.221
6. Ghajar CM, George SC, Putnam AJ. Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr 2008; 18:251-78; PMID: 18540825; http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v18.i3.30
7. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31; PMID:7584949; http://dx.doi.org/10.1038/nm0195- 27
8. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-64; PMID:8756718; http://dx.doi.org/10.1016/S0092-8674(00)80108-7
9. Folkman J, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991; 22:339-47; PMID:1726933
10. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol 2009; 9:259-70; PMID:19282852; http://dx.doi.org/10.1038/nri2528
11. Zumsteg A, Christofori G. Corrupt policemen: inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 2009; 21:60-70; PMID:19125020; http://dx.doi.org/10.1097/CCO.0b013e32831bed7e
12. Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002; 7:177-89; PMID:12463738; http://dx.doi.org/ 10.1023/A:1020304003704
13. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006; 66:11238-46; PMID:17114237; http://dx.doi.org/10.1158/0008- 5472.CAN-06-1278
14. Giraudo E, Inoue M, Hanahan D. An aminobisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114:623-33; PMID:15343380
15. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008; 13:206-20; PMID:18328425; http://dx.doi.org/10.1016/j.ccr.2008.01.034
16. Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 2009; 206:1089-102; PMID:19398755; http://dx.doi.org/10.1084/jem. 20081605
17. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006; 95:272-81; PMID:16832418; http://dx.doi.org/10. 1038/sj.bjc.6603240
18. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990; 87:6624-8; PMID:1697685; http://dx.doi.org/10.1073/pnas. 87.17.6624
19. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265:1582-4; PMID:7521539; http://dx.doi.org/10.1126/science.7521539
20. Myers C, Charboneau A, Cheung I, Hanks D, Boudreau N. Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol 2002; 161:2099-109; PMID:12466126; http://dx.doi.org/10.1016/S0002-9440(10)64488-4
21. Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF. Heterogeneity of the tumor vasculature. Semin Thromb Hemost 2010; 36:321-31; PMID:20490982; http://dx.doi.org/10.1055/s-0030-1253454
22. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978; 276:565-70; PMID:103000; http://dx.doi.org/10.1038/276565a0
23. Krumlauf R. Hox genes in vertebrate development. Cell 1994; 78:191-201; PMID:7913880; http://dx.doi.org/10.1016/0092-8674(94)90290-9
24. Wellik DM. Hox genes and vertebrate axial pattern. Curr Top Dev Biol 2009; 88:257-78; PMID:19651308; http://dx.doi.org/10.1016/S0070-2153(09)88009-5
25. Lufkin T, Mark M, Hart CP, Dollé P, LeMeur M, Chambon P. Homeotic transformation of the occipital bones of the skull by ectopic expression of a homeobox gene. Nature 1992; 359:835-41; PMID:1359423; http://dx.doi.org/10.1038/ 359835a0
26. Kessel M, Balling R, Gruss P. Variations of cervical vertebrae after expression of a Hox-1.1 transgene in mice. Cell 1990; 61:301-8; PMID:1970515; http://dx.doi.org/10.1016/0092-8674(90)90810-2
27. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921; PMID:11237011; http://dx.doi.org/10.1038/35057062
28. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992; 68:283-302; PMID:1346368; http://dx.doi.org/10.1016/0092-8674(92)90471-N
29. Condie BG, Capecchi MR. Mice with targeted disruptions in the paralogous genes hoxa-3 and hoxd-3 reveal synergistic interactions. Nature 1994; 370: 304-7; PMID:7913519; http://dx.doi.org/10.1038/370304a0
30. Davis AP, Witte DP, Hsieh-Li HM, Potter SS, Capecchi MR. Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. Nature 1995; 375:791-5; PMID:7596412; http://dx.doi.org/10.1038/375791a0
31. Horan GS, Ramírez-Solis R, Featherstone MS, Wolgemuth DJ, Bradley A, Behringer RR. Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed. Genes Dev 1995; 9:1667-77; PMID:7628700; http://dx.doi.org/10.1101/gad.9.13.1667
32. Horan GS, Kovàcs EN, Behringer RR, Featherstone MS. Mutations in paralogous Hox genes result in overlapping homeotic transformations of the axial skeleton: evidence for unique and redundant function. Dev Biol 1995; 169:359-72; PMID:7750651; http://dx.doi.org/10.1006/dbio.1995.1150
33. Fromental-Ramain C, Warot X, Lakkaraju S, Favier B, Haack H, Birling C, et al. Specific and redundant functions of the paralogous Hoxa-9 and Hoxd-9 genes in forelimb and axial skeleton patterning. Development 1996; 122:461-72; PMID:8625797
34. Greer JM, Puetz J, Thomas KR, Capecchi MR. Maintenance of functional equivalence during paralogous Hox gene evolution. Nature 2000; 403:661-5; PMID:10688203; http://dx.doi.org/10.1038/35001077
35. Davis AP, Capecchi MR. A mutational analysis of the 5′ HoxD genes: dissection of genetic interactions during limb development in the mouse. Development 1996; 122:1175-85; PMID:8620844
36. de la Cruz CC, Der-Avakian A, Spyropoulos DD, Tieu DD, Carpenter EM. Targeted disruption of Hoxd9 and Hoxd10 alters locomotor behavior, vertebral identity, and peripheral nervous system development. Dev Biol 1999; 216:595-610; PMID:10642795; http://dx.doi.org/10.1006/dbio.1999.9528
37. Rancourt DE, Tsuzuki T, Capecchi MR. Genetic interaction between hoxb-5 and hoxb-6 is revealed by nonallelic noncomplementation. Genes Dev 1995; 9: 108-22; PMID:7828847; http://dx.doi.org/10.1101/gad.9.1.108
38. Favier B, Rijli FM, Fromental-Ramain C, Fraulob V, Chambon P, Dollé P. Functional cooperation between the non-paralogous genes Hoxa-10 and Hoxd-11 in the developing forelimb and axial skeleton. Development 1996; 122:449-60; PMID:8625796
39. Chisaka O, Capecchi MR. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 1991; 350:473-9; PMID:1673020; http://dx.doi.org/10.1038/350473a0
40. Bergwerff M, Gittenberger-de Groot AC, Wisse LJ, DeRuiter MC, Wessels A, Martin JF, et al. Loss of function of the Prx1 and Prx2 homeobox genes alters architecture of the great elastic arteries and ductus arteriosus. Virchows Arch 2000; 436:12-9; PMID:10664157; http://dx.doi.org/10.1007/PL00008193
41. Miano JM, Firulli AB, Olson EN, Hara P, Giachelli CM, Schwartz SM. Restricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cells. Proc Natl Acad Sci U S A 1996; 93:900-5; PMID:8570656; http://dx.doi.org/10.1073/pnas.93.2.900
42. Wu Y, Moser M, Bautch VL, Patterson C. HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells. Mol Cell Biol 2003; 23:5680-91; PMID:12897140; http://dx.doi.org/10.1128/MCB.23.16.5680-5691.2003
43. Bahrami SB, Veiseh M, Dunn AA, Boudreau NJ. Temporal changes in Hox gene expression accompany endothelial cell differentiation of embryonic stem cells. Cell Adh Migr 2011; 5:133-41; PMID:21200152; http://dx.doi.org/10.4161/cam.5.2. 14373
44. Iacovino M, Chong D, Szatmari I, Hartweck L, Rux D, Caprioli A, et al. HoxA3 is an apical regulator of haemogenic endothelium. Nat Cell Biol 2011; 13:72-8; PMID:21170035; http://dx.doi.org/10.1038/ncb2137
45. Rössig L, Urbich C, Brühl T, Dernbach E, Heeschen C, Chavakis E, et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005; 201:1825-35; PMID:15928198; http://dx.doi.org/10.1084/jem.20042097
46. Crompton MR, Bartlett TJ, MacGregor AD, Manfioletti G, Buratti E, Giancotti V, et al. Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells. Nucleic Acids Res 1992; 20:5661-7; PMID:1360645; http://dx.doi.org/10.1093/nar/20.21.5661
47. Hallaq H, Pinter E, Enciso J, McGrath J, Zeiss C, Brueckner M, et al. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 2004; 131: 5197-209; PMID:15459110; http://dx.doi.org/10.1242/dev.01393
48. Nakagawa T, Abe M, Yamazaki T, Miyashita H, Niwa H, Kokubun S, et al. HEX acts as a negative regulator of angiogenesis by modulating the expression of angiogenesis-related gene in endothelial cells in vitro. Arterioscler Thromb Vasc Biol 2003; 23:231-7; PMID:12588764; http://dx.doi.org/10.1161/01.ATV. 0000052670.55321.87
49. Minami T, Murakami T, Horiuchi K, Miura M, Noguchi T, Miyazaki J, et al. Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling. J Biol Chem 2004; 279: 20626-35; PMID:15016828; http://dx.doi.org/10.1074/jbc. M308730200
50. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997; 139:257-64; PMID:9314544; http://dx.doi.org/10.1083/jcb.139.1.257
51. Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004; 279:4862-8; PMID:14610084; http://dx.doi.org/10.1074/jbc.M305190200
52. Charboneau A, East L, Mulholland N, Rohde M, Boudreau N. Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis 2005; 8:289-96; PMID:16328158; http://dx.doi.org/10.1007/s10456-005-9016-7
53. Park H, Choi HJ, Kim J, Kim M, Rho SS, Hwang D, et al. Homeobox D1 regulates angiogenic functions of endothelial cells via integrin â1 expression. Biochem Biophys Res Commun 2011; 408:186-92; PMID:21501586; http://dx.doi.org/10.1016/j.bbrc.2011.04.017
54. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264:569-71; PMID:7512751; http://dx.doi.org/10.1126/science.7512751
55. Kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 2000; 156:1345-62; PMID:10751360; http://dx.doi.org/10. 1016/S0002-9440(10)65005-5
56. Mace KA, Hansen SL, Myers C, Young DM, Boudreau N. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 2005; 118:2567-77; PMID:15914537; http://dx.doi.org/10.1242/ jcs.02399
57. Myers C, Charboneau A, Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000; 148:343-51; PMID:10648567; http://dx.doi.org/10.1083/jcb.148.2.343
58. Hansen SL, Myers CA, Charboneau A, Young DM, Boudreau N. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 2003; 163:2421-31; PMID:14633614; http://dx.doi.org/10.1016/S0002-9440(10)63597-3
59. Patel CV, Sharangpani R, Bandyopadhyay S, DiCorleto PE. Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9. J Biol Chem 1999; 274:1415-22; PMID:9880515; http://dx.doi.org/10.1074/jbc.274.3.1415
60. Bruhl T, Urbich C, Aicher D, Acker-Palmer A, Zeiher AM, Dimmeler S. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res 2004; 94: 743-51; PMID:14764452; http://dx.doi.org/10.1161/01.RES.0000120861.27064.09
61. Chen A, Cuevas I, Kenny PA, Miyake H, Mace K, Ghajar C, et al. Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity. Cancer Res 2009; 69: 6721-9; PMID:19654314; http://dx.doi.org/10.1158/0008-5472.CAN-08-4069
62. Rhoads K, Arderiu G, Charboneau A, Hansen SL, Hoffman W, Boudreau N. A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol 2005; 3:240-52; PMID:16379594; http://dx.doi.org/10.1089/lrb.2005.3.240
63. Arderiu G, Cuevas I, Chen A, Carrio M, East L, Boudreau NJ. HoxA5 stabilizes adherens junctions via increased Akt1. Cell Adh Migr 2007; 1:185-95; PMID:19262140; http://dx.doi.org/10.4161/cam.1.4.5448
64. Winnik S, Klinkert M, Kurz H, Zoeller C, Heinke J, Wu Y, et al. HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2. Cardiovasc Res 2009; 83: 558-65; PMID:19403561; http://dx.doi.org/10.1093/cvr/cvp133
65. Gorski DH, LePage DF, Patel CV, Copeland NG, Jenkins NA, Walsh K. Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol 1993; 13:3722-33; PMID:8098844
66. Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev 1997; 11:1674-89; PMID:9224717; http://dx.doi.org/ 10.1101/gad.11.13.1674
67. Gorski DH, Leal AJ. Inhibition of endothelial cell activation by the homeobox gene Gax. J Surg Res 2003; 111:91-9; PMID:12842453; http://dx.doi.org/10.1016/S0022-4804(03)00042-8
68. Douville JM, Cheung DY, Herbert KL, Moffatt T, Wigle JT. Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells. PLoS One 2011; 6:e29099; PMID:22206000; http://dx.doi.org/10.1371/journal.pone.0029099
69. Patel S, Leal AD, Gorski DH. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression. Cancer Res 2005; 65:1414-24; PMID:15735029; http://dx.doi.org/10. 1158/0008-5472.CAN-04-3431
70. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111:1217-26; PMID:17957028; http://dx.doi.org/10.1182/blood-2007-07- 104133
71. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341:738-46; PMID:10471461; http://dx.doi.org/10.1056/NEJM199909023411006
72. DiPietro LA, Burns AL. Wound Healing: Methods and Protocols. Humana Press, 2003.
73. Mace KA, Restivo TE, Rinn JL, Paquet AC, Chang HY, Young DM, et al. HOXA3 modulates injuryinduced mobilization and recruitment of bone marrow-derived cells. Stem Cells 2009; 27:1654-65; PMID:19544454; http://dx.doi.org/10.1002/ stem.90
74. Mahdipour E, Charnock JC, Mace KA. Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells. Blood 2011; 117:815-26; PMID:20974673; http://dx.doi.org/10.1182/blood-2009-12- 259549
75. Maclauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, et al. Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and -9, and soluble VEGF. J Histochem Cytochem 2009; 57:301-13; PMID:19029404; http://dx.doi.org/10.1369/jhc.2008.952689
76. Mack JA, Abramson SR, Ben Y, Coffin JC, Rothrock JK, Maytin EV, et al. Hoxb13 knockout adult skin exhibits high levels of hyaluronan and enhanced wound healing. FASEB J 2003; 17:1352-4; PMID:12759339
77. Mack JA, Maytin EV. Persistent inflammation and angiogenesis during wound healing in K14-directed Hoxb13 transgenic mice. J Invest Dermatol 2010; 130:856-65; PMID:19759546; http://dx.doi.org/10.1038/jid.2009.305
78. Hansen SL, Dosanjh A, Young DM, Boudreau N, Hoffman WY. Hemangiomas and homeobox gene expression. J Craniofac Surg 2006; 17:767-71; PMID:16877932; http://dx.doi.org/10.1097/00001665-200607000-00031
79. Zhu Y, Cuevas IC, Gabriel RA, Su H, Nishimura S, Gao P, et al. Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain. J Neuropathol Exp Neurol 2009; 68:626-32; PMID:19458547; http://dx.doi.org/10.1097/NEN.0b013e3181a491ce
80. Caré A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, et al. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 1996; 16:4842-51; PMID:8756643
81. Caré A, Silvani A, Meccia E, Mattia G, Peschle C, Colombo MP. Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene 1998; 16:3285-9; PMID:9681827; http://dx.doi.org/10.1038/ sj.onc.1201875
82. Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, et al. HOXB7: a key factor for tumorassociated angiogenic switch. Cancer Res 2001; 61: 6532-9; PMID:11522651
83. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A 2002; 99:11205-10; PMID:12163646; http://dx.doi.org/10.1073/ pnas.172161899
84. Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, et al. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A 2010; 107:1100-5; PMID:20080567; http://dx.doi.org/10.1073/pnas.0912710107
85. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994; 55:410-22; PMID:7509844
86. Giraudo E, Inoue M, Hanahan D. An aminobisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004; 114:623-33; PMID:15343380
87. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 2005; 438:820-7; PMID:16341007; http://dx.doi.org/ 10.1038/nature04186
88. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 2009; 4:e6562; PMID:19668347; http://dx.doi.org/10.1371/journal.pone.0006562
89. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006; 8:1369-75; PMID:17128264; http://dx.doi.org/10.1038/ncb1507
90. Page SH, Wright EK, Jr., Gama L, Clements JE. Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One 2011; 6:e22052; PMID:21760952; http://dx.doi.org/10.1371/journal.pone.0022052
91. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083-94; PMID:17825402; http://dx.doi.org/10.1016/j.cell.2007.08.019
92. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007; 26:6766-76; PMID:17934484; http://dx.doi.org/10. 1038/sj.onc.1210760
93. Mahdipour E, Mace KA. Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration. Expert Opin Biol Ther 2011; 11:1079-90; PMID:21513461; http://dx.doi.org/10.1517/ 14712598.2011.579096
94. Yu BD, Hanson RD, Hess JL, Horning SE, Korsmeyer SJ. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc Natl Acad Sci U S A 1998; 95: 10632-6; PMID:9724755; http://dx.doi.org/10.1073/pnas.95.18.10632
95. Déjardin J, Cavalli G. Epigenetic inheritance of chromatin states mediated by Polycomb and trithorax group proteins in Drosophila. Prog Mol Subcell Biol 2005; 38:31-63; PMID:15881890; http://dx.doi.org/10.1007/3-540- 27310-7-2
96. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 2007; 128:735-45; PMID:17320510; http://dx.doi.org/10.1016/j.cell.2007.02.009
97. Schuettengruber B, Martinez AM, Iovino N, Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol 2011; 12: 799-814; PMID:22108599; http://dx.doi.org/10.1038/nrm3230
98. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125:301-13; PMID:16630818; http://dx.doi.org/10.1016/j.cell.2006.02. 043
99. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441:349-53; PMID:16625203; http://dx.doi.org/10.1038/ nature04733
100. Diehl F, Rössig L, Zeiher AM, Dimmeler S, Urbich C. The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation. Blood 2007; 109:1472-8; PMID:17047146; http://dx.doi.org/10.1182/ blood-2006-08-039651
101. Jung JH, Choi HJ, Maeng YS, Choi JY, Kim M, Kwon JY, et al. Mel-18, a mammalian Polycomb gene, regulates angiogenic gene expression of endothelial cells. Biochem Biophys Res Commun 2010; 400:523-30; PMID:20801102; http://dx.doi.org/10.1016/j.bbrc.2010.08.086
102. Park JH, Lee JY, Shin DH, Jang KS, Kim HJ, Kong G. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway. Oncogene 2011; 30:4578-89; PMID:21602890; http://dx.doi.org/10.1038/onc.2011.174
103. Shaw T, Martin P. Epigenetic reprogramming during wound healing: loss of polycomb-mediated silencing may enable upregulation of repair genes. EMBO Rep 2009; 10:881-6; PMID:19575012; http://dx.doi.org/10.1038/embor.2009.102
104. Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 2004; 15:57-67; PMID:15225548; http://dx.doi.org/10.1016/j.molcel.2004.06.020
105. Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A, et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 2009; 114:2733-43; PMID:19638619; http://dx.doi.org/10. 1182/blood-2009-03-213496
106. Reynolds PA, Sigaroudinia M, Zardo G, Wilson MB, Benton GM, Miller CJ, et al. Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem 2006; 281:24790-802; PMID:16766534; http://dx.doi.org/10.1074/jbc.M604175200
107. Huo R, Ma Q, Wu JJ, Chin-Nuke K, Jing Y, Chen J, et al. Noninvasive electromagnetic fields on keratinocyte growth and migration. J Surg Res 2010; 162:299-307; PMID:19592020; http://dx.doi.org/10.1016/j.jss.2009.02.016
108. Russell SB, Russell JD, Trupin KM, Gayden AE, Opalenik SR, Nanney LB, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010; 130:2489-96; PMID:20555348; http://dx.doi.org/10.1038/jid.2010. 162
109. Carrio M, Arderiu G, Myers C, Boudreau NJ. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res 2005; 65:7177-85; PMID:16103068; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1717
110. Wang Z, Dahiya S, Provencher H, Muir B, Carney E, Coser K, et al. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer. Clin Cancer Res 2007; 13:6327-34; PMID:17975144; http://dx.doi.org/10.1158/1078-0432.CCR-07-0310
111. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarraybased methylated CpG island recovery assay. Proc Natl Acad Sci U S A 2007; 104:5527-32; PMID:17369352; http://dx.doi.org/10.1073/pnas.0701059104
112. Takahashi O, Hamada J, Abe M, Hata S, Asano T, Takahashi Y, et al. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol Rep 2007; 17:753-60; PMID:17342311
113. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7:823-33; PMID:17957188; http://dx.doi.org/10.1038/nrc2253
114. Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003; 102:262-8; PMID:12637319; http://dx.doi.org/10.1182/blood-2002-10-3221
115. Armstrong SA, Golub TR, Korsmeyer SJ. MLL-rearranged leukemias: insights from gene expression profiling. Semin Hematol 2003; 40:268-73; PMID:14582077; http://dx.doi.org/10.1016/S0037-1963(03)00196-3
116. Jung C, Kim RS, Lee SJ, Wang C, Jeng MH. HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res 2004; 64: 3046-51; PMID:15126340; http://dx.doi.org/10.1158/0008-5472.CAN-03-2614
117. Jung C, Kim RS, Zhang H, Lee SJ, Sheng H, Loehrer PJ, et al. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer 2005; 92:2233-9; PMID:15928669; http://dx.doi.org/10.1038/sj.bjc.6602631
118. Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, et al. The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A 2012; 109: 2736-41; PMID:21690342; http://dx.doi.org/10.1073/pnas.1018859108
119. Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, et al. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest 2010; 120:1535-50; PMID:20389018; http://dx.doi.org/10.1172/JCI39534
120. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 1997; 89:1922-30; PMID:9058712
121. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-7; PMID:10521349; http://dx.doi.org/10.1126/science.286.5439.531
122. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002; 2:777-85; PMID:12360280; http://dx.doi.org/10. 1038/nrc907
123. Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther 2007; 6:1284-8; PMID:17660710
124. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449:682-8; PMID:17898713; http://dx.doi.org/10.1038/nature06174
125. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10:361-71; PMID:20357775; http://dx.doi.org/10.1038/nrc2826
126. González-Reyes A, Morata G. The developmental effect of overexpressing a Ubx product in Drosophila embryos is dependent on its interactions with other homeotic products. Cell 1990; 61:515-22; PMID: 1970762; http://dx.doi.org/10.1016/0092-8674(90)90533-K
127. Capovilla M, Botas J. Functional dominance among Hox genes: repression dominates activation in the regulation of Dpp. Development 1998; 125:4949-57; PMID:9811579
128. González-Reyes A, Urquia N, Gehring WJ, Struhl G, Morata G. Are cross-regulatory interactions between homoeotic genes functionally significant? Nature 1990; 344:78-80; PMID:1968232; http://dx.doi.org/10.1038/344078a0
129. Duboule D. Patterning in the vertebrate limb. Curr Opin Genet Dev 1991; 1:211-6; PMID:1688004; http://dx.doi.org/10.1016/S0959-437X(05)80072-3
130. Schöck F, Reischl J, Wimmer E, Taubert H, Purnell BA, Jäckle H. Phenotypic suppression of empty spiracles is prevented by buttonhead. Nature 2000; 405:351-4; PMID:10830964; http://dx.doi.org/10.1038/35012620
131. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304:594-6; PMID:15105502; http://dx.doi.org/10.1126/science. 1097434
132. Yekta S, Tabin CJ, Bartel DP. MicroRNAs in the Hox network: an apparent link to posterior prevalence. Nat Rev Genet 2008; 9:789-96; PMID:18781158; http://dx.doi.org/10.1038/nrg2400
133. Heuer JG, Li K, Kaufman TC. The Drosophila homeotic target gene centrosomin (cnn) encodes a novel centrosomal protein with leucine zippers and maps to a genomic region required for midgut morphogenesis. Development 1995; 121:3861-76; PMID:8582295
134. Wang BB, Müller-Immergluck MM, Austin J, Robinson NT, Chisholm A, Kenyon C. A homeotic gene cluster patterns the anteroposterior body axis of C. elegans. Cell 1993; 74:29-42; PMID:8101474; http://dx.doi.org/10.1016/0092- 8674(93)90292-X
135. Lamka ML, Boulet AM, Sakonju S. Ectopic expression of UBX and ABD-B proteins during Drosophila embryogenesis: competition, not a functional hierarchy, explains phenotypic suppression. Development 1992; 116:841-54; PMID:1363544
136. Barolo S, Posakony JW. Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling. Genes Dev 2002; 16:1167-81; PMID:12023297; http://dx.doi.org/10.1101/gad.976502
137. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML. Pbx proteins display hexapep-tide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 1995; 9:663-74; PMID:7729685; http://dx.doi.org/10. 1101/gad.9.6.663
138. Shen WF, Chang CP, Rozenfeld S, Sauvageau G, Humphries RK, Lu M, et al. Hox homeodomain proteins exhibit selective complex stabilities with Pbx and DNA. Nucleic Acids Res 1996; 24:898-906; PMID:8600458; http://dx.doi.org/10.1093/ nar/24.5.898
139. Shen WF, Rozenfeld S, Kwong A, Köm ves LG, Lawrence HJ, Largman C. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 1999; 19:3051-61; PMID:10082572
140. Azpiazu N, Morata G. Functional and regulatory interactions between Hox and extradenticle genes. Genes Dev 1998; 12:261-73; PMID:9436985; http://dx.doi.org/10.1101/gad.12.2.261
141. Jaffe L, Ryoo HD, Mann RS. A role for phosphorylation by casein kinase II in modulating Antennapedia activity in Drosophila. Genes Dev 1997; 11:1327-40; PMID:9171376; http://dx.doi.org/10.1101/gad.11.10.1327
142. Ronshaugen M, McGinnis N, McGinnis W. Hox protein mutation and macroevolution of the insect body plan. Nature 2002; 415:914-7; PMID: 11859370; http://dx.doi.org/10.1038/nature716
143. Chen H, Chung S, Sukumar S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 2004; 24:924-35; PMID: 14701762; http://dx.doi.org/10.1128/MCB.24.2.924-935.2004
144. Stelnicki EJ, Arbeit J, Cass DL, Saner C, Harrison M, Largman C. Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal wounds. J Invest Dermatol 1998; 111:57-63; PMID:9665387; http://dx.doi.org/10. 1046/j.1523-1747.1998.00238.x
145. Jain K, Sykes V, Kordula T, Lanning D. Homeobox genes Hoxd3 and Hoxd8 are differentially expressed in fetal mouse excisional wounds. J Surg Res 2008; 148: 45-8; PMID:18570930; http://dx.doi.org/10.1016/j.jss.2008.02.053
146. Stelnicki EJ, Kömüves LG, Holmes D, Clavin W, Harrison MR, Adzick NS, et al. The human homeobox genes MSX-1, MSX-2, and MOX-1 are differentially expressed in the dermis and epidermis in fetal and adult skin. Differentiation 1997; 62:33-41; PMID:9373945; http://dx.doi.org/10.1046/j.1432- 0436.1997.6210033.x